There is a misconception that people with skin of color are not at risk of skin cancer, and dermatologists are responsible for better educating themselves and their patients about this danger, says an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
Active chemicals found in the neem tree (Azadirachta indica) have important benefits for a variety of skin disorders, according to one expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
No cryptic cartel, the American Medical Association (AMA)/Specialty Society Relative Value Scale Update Committee (RUC) is an indispensable piece of the healthcare payment puzzle that beats less logical options that have been proposed, dermatologists say.
Dermatologists generally know that the sensitivity of many pathogens to the antibiotics used to treat them is decreasing, experts say. But many dermatologists may not appreciate their specialty’s role in potentially fueling the problem.
Popular media coverage of purported links between isotretinoin and inflammatory bowel disease (IBD) are largely overblown, as are patients’ concerns regarding the risks of oral contraceptive pills (OCPs) for acne, according to an expert.
Even though bacteria such as Propionibacterium acnes share the same genus and species, says an expert, recent research suggests that different P. acnes strains may behave differently, which could have profound implications for acne treatment.
With isotretinoin disappearing from continuous medical education (CME), says an expert, dermatologists must take the initiative in promoting best practices for this indispensable acne drug.
Recent developments regarding acne and rosacea in skin of color include studies showing that combination topical products for acne appear safe in this population, and the fact that rosacea is perhaps more prevalent than many might expect.
Even though patients may present with clinically similar acne, says an expert, their expectations and preferences for particular treatments may differ vastly.
With acne presenting in increasingly younger patients, new guidelines developed by the American Acne and Rosacea Society (AARS) promote more consistent care for pediatric patients, according to an expert.